Forum

Failing the vulnerable: Three new consent norms that will undermine health research with children

Ann Strode, Marlise Richter, Melissa Wallace, Jacintha Toohey, Karl Technau
Southern African Journal of HIV Medicine | Vol 15, No 2 | a18 | DOI: https://doi.org/10.4102/sajhivmed.v15i2.18 | © 2014 Ann Strode, Marlise Richter, Melissa Wallace, Jacintha Toohey, Karl Technau | This work is licensed under CC Attribution 4.0
Submitted: 12 December 2014 | Published: 23 May 2014

About the author(s)

Ann Strode, University of KwaZulu-Natal and HIV/AIDS Vaccines Ethics Group, Durban, South Africa, South Africa
Marlise Richter, International Centre for Reproductive Health, Department of Obstetrics and Gynaecology, Ghent University, Belgium; School of Public Health and Family Medicine, University of Cape Town, South Africa; African Centre for Migration and Society, University of the Witwatersrand, Johannesburg, South Africa
Melissa Wallace, Desmond Tutu HIV Foundation, University of Cape Town, South Africa
Jacintha Toohey, HIV/AIDS Vaccines Ethics Group, Durban, South Africa
Karl Technau, Empilweni Services and Research Unit, Department of Paediatrics and Child Health, Rahima Moosa Mother and Child Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Full Text:

PDF (111KB)

Abstract

The South African National Health Act (No. 61 of 2003) provides a legal framework for the regulation of the health system across the country. Within the Act, section 71 introduces a number of legal norms relating to research or experimentation with human subjects, including research on HIV prevention and treatment. These norms have been criticised for the negative impact they will have on research involving children. This article describes three of the new consent requirements in section 71 of the Act. It shows, using a range of case studies, how important HIV-related research will be halted or undermined if the current provisions are implemented. The article argues that the new consent requirements are out of step with other statutory provisions and ethical guidelines, and as a result they will exclude a large population group – children in diverse settings – from much-needed evidence-based healthcare interventions. The article concludes with a clarion call for support of advocacy on this issue with the Minister of Health and the Health Portfolio Committee.


Keywords

HIV AIDS; Children; Law; Consent; legislation; proxy; parental consent

Metrics

Total abstract views: 5997
Total article views: 2886

 

Crossref Citations

1. Adolescent participation in HIV research: consortium experience in low and middle-income countries and scoping review
Suzanne Day, Bill G Kapogiannis, Seema K Shah, Erin C Wilson, Theodore D Ruel, Donaldson F Conserve, Ann Strode, Geri R Donenberg, Pamela Kohler, Catherine Slack, Oliver Ezechi, Joseph D Tucker
The Lancet HIV  vol: 7  issue: 12  first page: e844  year: 2020  
doi: 10.1016/S2352-3018(20)30269-1

2. Parental waivers to enable adolescent participation in certain forms of health research: lessons from a South African case study
Ann Strode, Zaynab Essack
BMC Medical Ethics  vol: 23  issue: 1  year: 2022  
doi: 10.1186/s12910-022-00833-5

3. Informed consent approaches for clinical trial participation of infants with minor parents in sub-Saharan Africa: A systematic review
Angela De Pretto-Lazarova, Domnita Oana Brancati-Badarau, Christian Burri, Simeon-Pierre Choukem
PLOS ONE  vol: 15  issue: 8  first page: e0237088  year: 2020  
doi: 10.1371/journal.pone.0237088

4. Insisting on prospective consent in paediatric critical care research may be throwing the baby out with the bathwater
Rebecca Doyle, Craig A McBride, Elizabeth Forster, Helen Petsky
Journal of Paediatrics and Child Health  vol: 58  issue: 9  first page: 1520  year: 2022  
doi: 10.1111/jpc.16144